Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam J Gehring

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Plos One|August 31, 2011
Licensing virus-specific T cells to secrete the neutrophil attracting chemokine CXCL-8 during hepatitis B virus infectionAdam J Gehring, Sarene Koh, Adeline Chia, et al.
Journal of Hepatology|June 12, 2023
Comment on 'End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB'Antonio Bertoletti, Nina Le Bert, Anthony T Tan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 31, 2024
Liver-restricted Type I IFN Signature Precedes Liver Damage in Chronic Hepatitis B Patients Stopping Antiviral TherapyConan Chua, Deeqa Mahamed, Shirin Nkongolo, et al.
Cell Stem Cell|October 15, 2024
Embryonic macrophages support endocrine commitment during human pancreatic differentiationAdriana Migliorini, Sabrina Ge, Michael H Atkins, et al.
Journal of Virology|January 5, 2007
The level of viral antigen presented by hepatocytes influences CD8 T-cell functionAdam J Gehring, Dianxing Sun, Patrick T F Kennedy, et al.
Journal of Virology|December 17, 2010
Targeting hepatitis B virus-infected cells with a T-cell receptor-like antibodyKonduru S R Sastry, Chien Tei Too, Kaval Kaur, et al.
JHEP Reports : Innovation in Hepatology|August 21, 2023
Efficacy of antiviral therapy and host-virus interactions visualised using serial liver sampling with fine-needle aspiratesSamuel C Kim, Jeffrey J Wallin, Yanal Ghosheh, et al.
Journal of Viral Hepatitis|September 13, 2021
Effects of on-treatment ALT flares on serum HBsAg and HBV RNA in patients with chronic HBV infectionHannah S J Choi, Milan J Sonneveld, Mina S Farag, et al.
The Lancet. Gastroenterology & Hepatology|July 27, 2025
Scientific and medical evidence informing expansion of hepatitis B treatment guidelinesPatrick T Kennedy, Lena Allweiss, Antonio Bertoletti, et al.
Molecular Therapy. Nucleic Acids|August 15, 2013
A practical approach to immunotherapy of hepatocellular carcinoma using T cells redirected against hepatitis B virusSarene Koh, Noriko Shimasaki, Rossarin Suwanarusk, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Plos One|August 31, 2011
Licensing virus-specific T cells to secrete the neutrophil attracting chemokine CXCL-8 during hepatitis B virus infectionAdam J Gehring, Sarene Koh, Adeline Chia, et al.
Journal of Hepatology|June 12, 2023
Comment on 'End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB'Antonio Bertoletti, Nina Le Bert, Anthony T Tan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 31, 2024
Liver-restricted Type I IFN Signature Precedes Liver Damage in Chronic Hepatitis B Patients Stopping Antiviral TherapyConan Chua, Deeqa Mahamed, Shirin Nkongolo, et al.
Cell Stem Cell|October 15, 2024
Embryonic macrophages support endocrine commitment during human pancreatic differentiationAdriana Migliorini, Sabrina Ge, Michael H Atkins, et al.
Journal of Virology|January 5, 2007
The level of viral antigen presented by hepatocytes influences CD8 T-cell functionAdam J Gehring, Dianxing Sun, Patrick T F Kennedy, et al.
Journal of Virology|December 17, 2010
Targeting hepatitis B virus-infected cells with a T-cell receptor-like antibodyKonduru S R Sastry, Chien Tei Too, Kaval Kaur, et al.
JHEP Reports : Innovation in Hepatology|August 21, 2023
Efficacy of antiviral therapy and host-virus interactions visualised using serial liver sampling with fine-needle aspiratesSamuel C Kim, Jeffrey J Wallin, Yanal Ghosheh, et al.
Journal of Viral Hepatitis|September 13, 2021
Effects of on-treatment ALT flares on serum HBsAg and HBV RNA in patients with chronic HBV infectionHannah S J Choi, Milan J Sonneveld, Mina S Farag, et al.
The Lancet. Gastroenterology & Hepatology|July 27, 2025
Scientific and medical evidence informing expansion of hepatitis B treatment guidelinesPatrick T Kennedy, Lena Allweiss, Antonio Bertoletti, et al.
Molecular Therapy. Nucleic Acids|August 15, 2013
A practical approach to immunotherapy of hepatocellular carcinoma using T cells redirected against hepatitis B virusSarene Koh, Noriko Shimasaki, Rossarin Suwanarusk, et al.
Pageof 9